Lip G.Y.H., Collet J.P., Caterina R.D., Fauchier L., Lane D.A., Larsen T.B., Marin F., Morais J., Narasimhan C., Olshansky B., Pierard L., Potpara T., Sarrafzadegan N., Sliwa K., Varela G., Vilahur G., Weiss T., Boriani G., Rocca B., Gorenek B., Savelieva I., Sticherling C., Kudaiberdieva G., Chao T.F., Violi F., Nair M., Zimerman L., Piccini J., Storey R., Halvorsen S., Gorog D., Rubboli A., Chin A., Scott-Millar R. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace. 1 November 2017. 19:1757-1758. 10.1093/europace/eux240
AÑO: 2017; IF: 5.231
